Idera Pharmaceuticals (IDRA)
1.75
+0.01 +0.57%
NASDAQ
Aug 16, 11:23
Delayed 2m
USD
View All Key Stats
IDRA Key Stats
| Income Statement | |
| Revenue (TTM) | 16.28M |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | -0.29 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | -40.62M |
| Profitability | |
| Gross Profit Margin (Quarterly) | -- |
| Profit Margin (Quarterly) | -3.98K% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield (TTM) | 0 |
| Price and Valuation | |
| Market Cap | 261.86M |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio (TTM) | 14.46 |
| PE Ratio (TTM) | -- |
| Price to Book Value | 2.903 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio (Quarterly) | 0.0048 |
| Free Cash Flow (Quarterly) | -17.68M |
| Return on Equity (TTM) | -53.86% |
View All IDRA News
IDRA News
-
WireHeadlineTime (ET)
-
Globe Newswire08/11 11:00
-
Yahoo08/07 19:49
-
MT Newswires08/07 17:50
-
MT Newswires08/07 17:17
-
SA Breaking News08/07 17:13
-
Globe Newswire08/07 17:00
-
SA Breaking News07/25 11:01
-
Yahoo07/11 14:40
-
PR Newswire07/05 06:55
-
Yahoo06/24 11:42
View All Events
IDRA Events
| Date | Type | Description |
|---|---|---|
| 06/07/2017 | Misc | Idera Pharmaceuticals Inc Annual General Meeting in 2016 |
| 05/04/2017 | Earnings | Idera Pharmaceuticals Inc First Quarter Earnings Results in 2017 |
| 03/15/2017 | Earnings | Idera Pharmaceuticals Inc Fourth Quarter Earnings Results in 2016 |
| 10/28/2016 | Earnings | Idera Pharmaceuticals Inc Third Quarter Earnings Results in 2016 |
IDRA Fundamentals
Income Statement View Statement
IDRA Ratings
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
Advertisement
IDRA One Page Reports
- One Page Report Download
IDRA Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Target Price | |
| Price | 1.75 |
| Price Target | Upgrade |
Edit
Profile
- URL: http://www.iderapharma.com
- Investor Relations URL: http://ir.iderapharma.com/phoenix.zhtml?c=208904&p=irol-irhome
- HQ State/Province: Massachusetts
- Sector: Healthcare
- Industry: Biotechnology
- Next Earnings Release: N/A
- Last Earnings Release: May. 04, 2017
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: N/A
- Description: Idera Pharmaceuticals Inc is a clinical stage biotechnology company. It is engaged in the discovery, development and commercialization of novel therapeutics for oncology and rare diseases.
IDRA Comparables
EditIDRA Excel Add-In Codes
- Name: =YCI("IDRA","name")
- Description: =YCI("IDRA","description")
- Sector: =YCI("IDRA","sector")
- Industry: =YCI("IDRA","industry")
- Est. Current Fiscal Year End: =YCI("IDRA","fye")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.
Other IDRA Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- IDRA Tweets Stocktwits
Advertisement
